Filter By
Search
-
ANNOUNCEMENT OF THE AVAILABILITY OF THE INFORMATION MEMORANDUM AND THE DOCUMENT "OTHER INFORMATION CONCERNING THE LEGAL, FINANCIAL AND ACCOUNTING CHARACTERISTICS" OF ONCODNA S.A.
This press release has been prepared and issued by OncoDNA S.A. pursuant to...
-
COMBINED GENERAL MEETING
IntegraGen's Combined Ordinary and Extraordinary General Meeting will be held on September 17 at 2 pm...
-
-
AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN
Agreement to a friendly takeover bid initiated by ONCODNA for INTEGRAGEN at a price...
-
INTEGRAGEN - S1 2020 SALES OF €4.7M UP +13 % AND CASH POSITION OF €5.8M
IntegraGen today announces its unaudited sales figures for the first half of 2020. The sales...
-
INTEGRAGEN ACHIEVES CE MARKING FOR MERCURY™, A CLOUD-BASED SOFTWARE APPLICATION FOR INTERPRETING MOLECULAR DATA FROM CANCER PATIENTS' TUMORS
IntegraGen announces the CE marking of its cloud-hosted online software application,...
-
INTEGRAGEN UPDATE - ALWAYS OPEN FOR YOUR PROJECTS
IntegraGen is following government recommendations and precautionary measures related to the...
-
INTEGRAGEN - ANNUAL RESULTS 2019
Sales growth (+201TP3Q), EBITDA positive in the second half and close to...
-
INTEGRAGEN ANNOUNCES AN AGREEMENT WITH A LEADING US CANCER CENTER FOR THE USE OF MERCURY™, THE ONCOLOGY SEQUENCING DATA INTERPRETATION AND REPORTING TOOL
IntegraGen announced today that the Dana Farber Cancer Institute will use MERCURYTM, IntegraGen's proprietary software, to...
-
COVID-19: MEASURES TO PROTECT EVERYONE AND ENSURE YOUR PROJECTS RUN SMOOTHLY
Dear IntegraGen customers and partners, We care about your satisfaction and understand that all...
